H.R. 4490House118th Congress (2023-2025)In Committee

To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

AI-Generated Summary

Updated January 20, 2026 at 9:39 AM UTC

The bill amends the Controlled Substances Act to let pharmacies ship certain controlled substances—specifically schedule III, IV, or V drugs—to a qualified healthcare practitioner who will administer or supervise the medication, rather than delivering them directly to the patient. This change is intended to streamline the delivery process for drugs that must be given under professional oversight and affects pharmacies, prescribing clinicians, and patients who receive these medications.

Key Provisions

Permits pharmacies to deliver schedule III, IV, or V controlled substances to an administering practitioner instead of the ultimate user.
Applies only to drugs approved or licensed under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act for administration under practitioner supervision.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions

HouseCommittee Latest Action

Referred to the Subcommittee on Health.

Health Subcommittee

July 7, 2023

View full timeline

HouseIntro Referral

Introduced in House

July 6, 2023

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Energy and Commerce Committee

July 6, 2023

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

July 7, 2023

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued July 6, 2023

118th CONGRESS

1st Session

H. R. 4490

IN THE HOUSE OF REPRESENTATIVES

July 6, 2023

Mr. Guthrie (for himself, Ms. Matsui, and Ms. Kuster) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

Delivery of certain substances by a pharmacy to an administering practitioner

Paragraph (2) of section 309A(a) of the Controlled Substances Act (21 U.S.C. 829a(a)) is amended to read as follows:

(2)

the controlled substance is a drug in schedule III, IV, or V that is, pursuant to the approval or licensure of such drug under the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act, to be administered by, or under the supervision of, the practitioner;